RECURSION PHARMACEUTICALS IN's ticker is RXRX and the CUSIP is 75629V104. A total of 88 filers reported holding RECURSION PHARMACEUTICALS IN in Q3 2021. The put-call ratio across all filers is 0.28 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $90,705,698 | +4.5% | 11,856,954 | +2.0% | 0.00% | +50.0% |
| Q2 2023 | $86,797,118 | +22.4% | 11,619,427 | +9.3% | 0.00% | 0.0% |
| Q1 2023 | $70,914,487 | -13.8% | 10,631,857 | -0.3% | 0.00% | -33.3% |
| Q4 2022 | $82,247,381 | -20.9% | 10,667,624 | +9.2% | 0.00% | -25.0% |
| Q3 2022 | $103,921,000 | +54.9% | 9,767,040 | +18.5% | 0.00% | +100.0% |
| Q2 2022 | $67,087,000 | +39.7% | 8,241,782 | +22.9% | 0.00% | +100.0% |
| Q1 2022 | $48,029,000 | -58.5% | 6,707,757 | -0.8% | 0.00% | -66.7% |
| Q4 2021 | $115,846,000 | +184.8% | 6,762,684 | +282.6% | 0.00% | +200.0% |
| Q3 2021 | $40,673,000 | -22.8% | 1,767,664 | +22.4% | 0.00% | 0.0% |
| Q2 2021 | $52,709,000 | – | 1,444,078 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Data Collective IV GP, LLC | 5,941,120 | $45,806,035 | 48.11% |
| Kinnevik AB (publ) | 7,653,061 | $59,005,100 | 33.28% |
| MV Management XI, L.L.C. | 1,971,908 | $15,203,411 | 26.45% |
| MIC Capital Management UK LLP | 8,451,758 | $65,163,057 | 12.86% |
| ArchPoint Investors | 1,114,626 | $8,593,766 | 4.07% |
| HARVARD MANAGEMENT CO INC | 1,509,254 | $11,636,348 | 1.44% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 2,710,339 | $20,896,714 | 0.80% |
| Duquesne Family Office | 1,385,950 | $10,685,675 | 0.53% |
| ALLEN OPERATIONS LLC | 217,657 | $1,678,135 | 0.45% |
| Artal Group S.A. | 960,204 | $7,403 | 0.41% |